Skip to main content
. 2022 Feb 23;14(5):1143. doi: 10.3390/cancers14051143

Figure 1.

Figure 1

Frequency of TP53 mutations in EGFR-mutated NSCLC patients, extracted by cBioPortal (https://www.cbioportal.org/, accessed on 28 January 2022). The percentage of TP53 codon mutations along all gene exons, and the most frequently mutated codons are reported. TA: transactivation domain; PR: proline rich domain; DBD: DNA binding domain; OD: oligomerization domain; CTD: carboxy-terminal domain.